---
title: "The innovative drug concept is repeatedly active, and BHC has hit the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233547243.md"
description: "BHC surged to the daily limit, R&G Pharma and Shouyao Holdings rose over 10%, while Hotgen, ApicHope, and Hinova also followed suit"
datetime: "2025-03-28T01:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233547243.md)
  - [en](https://longbridge.com/en/news/233547243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233547243.md)
generator: "portal-rs"
---

# The innovative drug concept is repeatedly active, and BHC has hit the daily limit

BHC surged to the daily limit, R&G Pharma and Shouyao Holdings rose over 10%, while Hotgen, ApicHope, and Hinova also followed suit

### Related Stocks

- [688197.CN](https://longbridge.com/en/quote/688197.CN.md)
- [688068.CN](https://longbridge.com/en/quote/688068.CN.md)
- [300723.CN](https://longbridge.com/en/quote/300723.CN.md)
- [600721.CN](https://longbridge.com/en/quote/600721.CN.md)
- [688302.CN](https://longbridge.com/en/quote/688302.CN.md)
- [301333.CN](https://longbridge.com/en/quote/301333.CN.md)

## Related News & Research

- [RemeGen Deploys Idle Funds Into Discloseable Wealth Management Products](https://longbridge.com/en/news/297779978.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [Biocytogen licenses fully human VHH antibody to Qilu Pharma in non-exclusive deal](https://longbridge.com/en/news/297781804.md)
- [Teqnion agrees to acquire Scotland-based Abercromby Vending](https://longbridge.com/en/news/297759475.md)
- [08:27 ETHyGen Promotes Omid Ghobadi to Chief Operating Officer](https://longbridge.com/en/news/297786116.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**